gold has been researched along with podophyllin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kruszewski, S; PakuĊa, A | 1 |
| Meyer, W | 1 |
| Bendix, G; Bjelle, A | 1 |
3 other study(ies) available for gold and podophyllin
| Article | Year |
|---|---|
[Evaluation of the effectiveness of anti-inflammatory treatment of rheumatoid arthritis by means of thermography].
Topics: Adolescent; Adult; Aged; Ampicillin; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Body Temperature; Chloroquine; Drug Evaluation; Female; Gold; Humans; Hydrazines; Male; Middle Aged; Podophyllin; Prednisone; Thermography; Thiosulfates | 1978 |
[Critical evaluation of rheumatism therapy. Basic drugs].
Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Azathioprine; Chloroquine; Evaluation Studies as Topic; Gold; Humans; Penicillamine; Podophyllin | 1975 |
Proresid therapy in rheumatoid arthritis. A comparison with injectable gold using life-table analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Cohort Studies; Female; Gold; Humans; Incidence; Injections; Life Tables; Male; Middle Aged; Neoplasms; Patient Compliance; Patient Dropouts; Podophyllin; Podophyllotoxin; Prognosis; Risk Factors; Treatment Outcome | 1993 |